Medical News

RSS

FDA grants final approval for Hi-Tech Pharmacal's ANDA for levofloxacin ophthalmic solution

Hi-Tech Pharmacal Co., Inc., a specialty pharmaceuticals company, announced today that the US Food and Drug Administration granted final approval for the Company's Abbreviated New Drug Application for levofloxacin ophthalmic solution, 0.5% the generic for Vistakon's Quixin ophthalmic solution, which had sales of $2 million for the 12 months ended December 2010 according to IMS sales data.

10 Feb 2011

Genta initiates new Phase 2 clinical trial of tesetaxel in patients with advanced prostate cancer

Genta Incorporated today announced that the Company has initiated a new Phase 2 clinical trial of tesetaxel in patients with advanced prostate cancer. Tesetaxel, the leading oral taxane in clinical development, will be evaluated for its use as both first- and second-line chemotherapy.

10 Feb 2011

Guide designed to help hospitals reduce variation in care

The American Hospital Association has released a guide to help hospitals and health care systems reduce inappropriate variation in areas such as end-of-life care, imaging, emergency services and obstetrics.

10 Feb 2011

Regular exercise improves ability of overweight children to think, do math: Researchers

Regular exercise improves the ability of overweight, previously inactive children to think, plan and even do math, Georgia Health Sciences University researchers report.

10 Feb 2011

Researchers find significant association between childhood physical abuses, peptic ulcers

Victims of childhood physical abuse are more than twice as likely to develop ulcers than people who were not abused as children, according to a new study from researchers at the University of Toronto.

10 Feb 2011

GE Healthcare, BHS announce planned implementation of HIE

GE Healthcare and Butler Health System, which serves Western Pennsylvania communities, have announced the planned implementation of a health information exchange to enable clinical information access between BHS and its affiliated and independent physicians, as well as referral hospitals outside of the immediate community.

10 Feb 2011

Analyst offers prediction about Medicare advantage plans

Initial 2012 reimbursement rates for Medicare Advantage plans should be roughly flat, which tops the consensus expectation of a 2 percent drop, according to Citi analyst Carl McDonald. McDonald said Tuesday in a research note the rates will be hurt by cuts from the health care overhaul, but he also thinks they will benefit from an adjustment to prior estimates.

10 Feb 2011

HERAE signs agreement with Aetna to offer electronic solutions

HERAE, one of the nation's largest healthcare electronic payment service providers, has signed an agreement with Aetna to offer electronic solutions that will make claim reconciliation, payments processing and deposits faster and more cost effective for doctors and hospitals that care for Aetna's members nationwide.

10 Feb 2011

Gilead resubmits NDA for single-tablet regimen of Truvada/TMC278

Gilead Sciences, Inc. announced today that it has refiled a New Drug Application (NDA) with the U.S. Food and Drug Administration (FDA) for the single-tablet regimen of Truvada® (emtricitabine and tenofovir disoproxil fumarate) and Tibotec Pharmaceuticals' investigational non-nucleoside reverse transcriptase inhibitor TMC278 (rilpivirine hydrochloride) for HIV-1 infection in adults.

10 Feb 2011

NeoGenomics fourth quarter revenue increases 12% to $8.8 million

NeoGenomics, Inc., a leading provider of cancer-focused genetic testing services, today reported its results for the fourth quarter 2010 and fiscal year ended December 31, 2010.

10 Feb 2011

Zogenix completes enrollment in ZX002 Phase 3 study in opioid-experienced adults with moderate to severe pain

Zogenix, Inc. announced today the completion of enrollment in its pivotal Phase 3 efficacy study (Study 801) of ZX002. ZX002 is a novel, oral, single-entity, controlled-release formulation of hydrocodone for the treatment of moderate to severe pain in patients requiring around-the-clock opioid therapy for an extended period of time.

10 Feb 2011

Cytomedix granted CE mark for Angel Blood Separation System and activAT Autologous Thrombin Processing Kit

Cytomedix, Inc. today announced that the Company has been issued a CE marking certification for its Angel® Whole Blood Separation System ("Angel") and its activAT® Autologous Thrombin Processing Kit ("activAT").

10 Feb 2011

First Edition: February 10, 2011

Today's headlines include news about how the legal skirmishes surrounding the health overhaul are heating up.

10 Feb 2011

Mallinckrodt receives FDA approval for Fentanyl Transdermal System patch ANDA

Covidien, a leading global provider of healthcare products, today announced that Mallinckrodt Inc., a Covidien company, has received U.S. Food and Drug Administration (FDA) approval of its Abbreviated New Drug Application (ANDA) for its Fentanyl Transdermal System (FTS) patch. Covidien is the largest supplier of controlled pain medications in the United States based on number of prescriptions.

10 Feb 2011

Momenta reports fourth quarter 2010 net income of $36.3M vs. $14.7M net loss for fourth quarter 2009

Momenta Pharmaceuticals, Inc., a biotechnology company specializing in the characterization and engineering of complex drugs, today reported its financial results for the fourth quarter and year ended December 31, 2010.

10 Feb 2011

Full genetic blueprint of multiple prostate tumors laid bare

For the first time, researchers have laid bare the full genetic blueprint of multiple prostate tumors, uncovering alterations that have never before been detected and offering a deep view of the genetic missteps that underlie the disease. The study, made possible by key advances in whole genome sequencing and analysis, points to several new prostate cancer genes and a critical category of genomic changes as important drivers of prostate cancer growth.

10 Feb 2011

Gallup-Healthways January 2011 Well-Being Index increases 0.7 points to 66.7

Please be advised that Gallup and Healthways, Inc. today released the Gallup-Healthways Monthly U.S. Well-Being Report for January 2011.

10 Feb 2011

Edward Hospital joins Premier healthcare alliance and saves $1,053,000

Edward Hospital & Health Services has saved more than $1 million by joining the Premier healthcare alliance. The full-service, regional healthcare provider based in Naperville, Ill., is also participating in programs to provide high-quality, cost-effective care.

10 Feb 2011

LabCorp fourth quarter net earnings decrease to $131.8 million

Laboratory Corporation of America® Holdings today announced results for the quarter and year ended December 31, 2010. These results include the operations of Genzyme Genetics for the month of December.

10 Feb 2011

TMJ Medical receives FDA postmarket surveillance study order

TMJ Medical acknowledged Tuesday receiving a postmarket surveillance study order from the U.S. Food and Drug Administration. TMJ Medical is one of three medical device manufacturers approved to market temporomandibular joint (TMJ) implants in the United States. Each manufacturer received the same FDA order.

10 Feb 2011

Medical News

FDA grants final approval for Hi-Tech Pharmacal's ANDA for levofloxacin ophthalmic solution

Genta initiates new Phase 2 clinical trial of tesetaxel in patients with advanced prostate cancer

Guide designed to help hospitals reduce variation in care

Regular exercise improves ability of overweight children to think, do math: Researchers

Researchers find significant association between childhood physical abuses, peptic ulcers

GE Healthcare, BHS announce planned implementation of HIE

Analyst offers prediction about Medicare advantage plans

HERAE signs agreement with Aetna to offer electronic solutions

Gilead resubmits NDA for single-tablet regimen of Truvada/TMC278

NeoGenomics fourth quarter revenue increases 12% to $8.8 million

Zogenix completes enrollment in ZX002 Phase 3 study in opioid-experienced adults with moderate to severe pain

Cytomedix granted CE mark for Angel Blood Separation System and activAT Autologous Thrombin Processing Kit

First Edition: February 10, 2011

Mallinckrodt receives FDA approval for Fentanyl Transdermal System patch ANDA

Momenta reports fourth quarter 2010 net income of $36.3M vs. $14.7M net loss for fourth quarter 2009

Full genetic blueprint of multiple prostate tumors laid bare

Gallup-Healthways January 2011 Well-Being Index increases 0.7 points to 66.7

Edward Hospital joins Premier healthcare alliance and saves $1,053,000

LabCorp fourth quarter net earnings decrease to $131.8 million

TMJ Medical receives FDA postmarket surveillance study order

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Latest News